Replies to post #267856 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Actually, I believe that:

The likelihood of such a corporate announcement (positive clinical results from both the Rett syndrome and Parkinson's disease dementia trials at the same time) are quite possible and may even probable.

Remember, there were only 31 subjects in the US Rett syndrome Anavex 2-73 trial. That is only about 1/4 or 1/5 of the number of subjects in the PDD trial in Spain and Australia.

the U.S. study is 18 years and older, and it sounds like very generous, but the reality is there's actually less patient pool for study available in older patients for various reasons. And we basically are happy that we were able to enroll, especially in the last few months, many more patients than we had actually planned for because we just had planned for 21 patients at the beginning, and then we added up 10 more to end up now at 31

Good luck and GOD bless,

[nidan7500]

falconer

However, were such an announcement made it would focus the public's and media's attention on one unique matter. A single drug successfully treated two very different central nervous system diseases. Writers and commenters would have to try to explain that. How could this happen?

Well, they have to learn someday...as in..."When you get to the edge, you will NOT fall off because....wait for it....IT'S ROUND".